Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • seqtechno1
    Member
    • May 2017
    • 21

    ddPCR for quantification of Illumina TruSeq library

    Hello,

    I am planning on using the BioRad Truseq ddPCR assay for Illumina quantification of a truseq cDNA library I made from RNA. The protocol calls for running dilutions of library in 10^-6, 10^-7, and 10^-8. The thing is, I am starting with very low concentration library to begin with, maybe on the order of 300pg/ul. Therefore, I am thinking of instead running something like 10^-2, 10^4, and 10^-6 dilutions instead, to make sure I don't over-dilute. Thoughts?
  • austinso
    Member
    • Jun 2012
    • 77

    #2
    Originally posted by seqtechno1 View Post
    Hello,

    I am planning on using the BioRad Truseq ddPCR assay for Illumina quantification of a truseq cDNA library I made from RNA. The protocol calls for running dilutions of library in 10^-6, 10^-7, and 10^-8. The thing is, I am starting with very low concentration library to begin with, maybe on the order of 300pg/ul. Therefore, I am thinking of instead running something like 10^-2, 10^4, and 10^-6 dilutions instead, to make sure I don't over-dilute. Thoughts?
    Let's assume that your average fragment length is 300bp + 150 bp adaptor.

    So, 300 pg/uL is 300e-12/(660*450)*6.022e23 ~ 6e8 molecules/uL

    You want to be around 2e4 copies/uL in the ddPCR reaction, so the stock should be drawing from should have around 2e5 copies/uL.

    So a 10^4 should be more than enough.

    That being said, you may not have enough library depending on which sequencer you are using and how much volume you have of your library.

    At least 10 copies/uL measured from a ddPCR reaction using a 10^6 dilution is about where you need to be.

    Just be sure that the ddPCR assay is compatible (i.e. the right version) with the TruSeq version you are using.

    Comment

    • seqtechno1
      Member
      • May 2017
      • 21

      #3
      hi austinso,

      thanks for the information. i'm going to run through the calculations so that i understand the math better. i will have enough for sequencing because i can normalize all of my libraries to 0.5nM, then just add more volume of these to equilibrate the relative abundances. i've already done those calculations. the ddPCR was just a learning exercise to make sure our primers and probes and everything are working. we got some nice (looking) data out of it, but i haven't analyzed it yet. it looks like 10^-6 was the most informative dilution.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:41 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...